c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro

Journal of Neuro-Oncology

Volumn 93, Issue 2, 2009, Pages 183-189

  Chu, Sheng Hua ^a   Feng, Dong Fu ^a   Zhang, Hong ^a   Chen, Er Tao ^a   Duan, Zhi Xin ^a   Li, Xue Yuan ^a   Li, Jia ^a   Ma, Yan Bin ^a   Zhu, Zhi An ^a   Qiu, Jian Hua ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adherence; Apoptosis; c Met; Gene therapy; Glioma; RNA interference

Indexed keywords

LIPOFECTAMINE; LIPOFECTAMINE 2000; MESSENGER RNA; SCATTER FACTOR RECEPTOR; SHORT HAIRPIN RNA; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO CULTURE; METASTASIS INHIBITION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GROWTH; WESTERN BLOTTING;

APOPTOSIS; CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; GENE AMPLIFICATION; GLIOMA; HUMANS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 66149135691     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9772-5     Document Type: Article

References (27)

1. Ramos-Nino ME, Blumen SR, Sabo-Attwood T, Pass H, Carbone M, Testa JR, Altomare DA, Mossman BT (2008) HGF mediates cell proliferation of human mesothelioma cells through a PI3 K/MEK5/Fra-1 pathway. Am J Respir Cell Mol Biol 38:209-217. doi: 10.1165/rcmb.2007-0206OC
2. Christensen JG, Burrows J, Salgia R (2005) c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett 225:1-26. doi: 10.1016/j.canlet.2004.09.044
3. Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocaña A (2005) Targeted inactivation of hepatocyte growth factor receptor c-Met in (beta)-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of (beta)-cell mass. Diabetes 54:2090-2102. doi: 10.2337/diabetes.54.7.2090
4. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Comoglio PM (1989) Tyrosine kinase receptor indistinguishable from the c-Met protein. Nature 339:155-156. doi: 10.1038/339155a0
5. Camp RL, Rimn EB, Rimm DL (1999) Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 86:2259-2265. doi: 10.1002/ (SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2
6. Cheng HL, Liu HS, Lin YJ, Chen HH, Hsu PY, Chang TY, Ho CL, Tzai TS, Chow NH (2005) Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder. Br J Cancer 92:1906-1914. doi: 10.1038/sj.bjc.6602593
7. Chu SH, Yuan XH, Li ZQ, Jiang PC, Zhang J (2006) C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells. Surg Neurol 65:533-538. doi: 10.1016/j.surneu.2005.11.024
8. Chu SH, Yuan XH, Jiang PC, Li ZQ, Zhang J, Wen ZH, Zhao SY, Chen XJ, Cao CJ (2005) The expression of hepatocyte growth factor and its receptor in brain astrocytomas. Zhonghua Yi Xue Za Zhi 85:835-838
9. Chu SH, Zhu ZA, Yuan XH, Li ZQ, Jiang PC (2006) In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides. J Neurooncol 80:143-149. doi: 10.1007/s11060-006-9174-5
10. Chu SH, Ma YB, Zhang H, Feng DF, Zhu ZA, Li ZQ, Yuan XH (2007) Hepatocyte growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells. J Neurooncol 85:33-38. doi: 10.1007/s11060-007-9387-2
11. Chu SH, Ma YB, Zhu ZA, Zhang H, Feng DF, Li ZQ, Yuan XH (2007) Radiation-enhanced hepatocyte growth factor secretion in malignant glioma cell lines. Surg Neurol 68:610-613. doi: 10.1016/ j.surneu.2006.12.050
12. Bernstein E, Caudy AA, Hammond SM, Hannon GJ (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-366. doi: 10.1038/35053110
13. Cioca DP, Aoki Y, Kiyosawa K (2003) RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther 10:125-133. doi: 10.1038/sj.cgt.7700544
14. Mukohara T, Civiello G, Davis IJ, Taffaro ML, Christensen J, Fisher DE, Johnson BE, Jänne PA (2005) Inhibition of the met receptor in mesothelioma. Clin Cancer Res 11:8122-8130. doi: 10.1158/ 1078-0432.CCR-05-1191
15. Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE, Nishimura EK, Golub TR, Fisher DE (2004) Critical role of CDK2 for melanoma growth linked to its melanocytespecific transcriptional regulation by MITF. Cancer Cell 6:565-576. doi: 10.1016/j.ccr.2004.10.014
16. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S (1998) Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249:73-77. doi: 10.1006/bbrc.1998.9078
17. Jiang Y, Xu W, Lu J, He F, Yang X (2001) Invasiveness of hepatocellular carcinoma cell lines: Contribution of hepatocyte growth factor, c-met, and transcription factor ets-1. Biochem Biophys Res Commun 286:1123-1130. doi: 10.1006/bbrc.2001.5521
18. Wang S, Liu H, Ren L, Pan Y, Zhang Y (2008) Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia 10:399-407
19. Uemura K, Takao S, Aikou T (1998) In vitro determination of basement membrane invasion predicts liver metastases in human gastrointestinal carcinoma. Cancer Res 58:3727-3731
20. Jin M, He S, Wörpel V, Ryan SJ, Hinton DR (2000) Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-alpha. Invest Ophthalmol Vis Sci 41:4324-4332
21. Wang SM, Zhu J, Pan LF, Liu YK (2008) Inhibitory effect of dimeric β peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice. World J Gastroenterol 14:3054-3058. doi: 10.3748/wjg.14.3054
22. Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2:727-739. doi: 10.1038/nrc905
23. Orgaz JL, Martínez-Poveda B, Fernández-García NI, Jiménez B (2008) Following up tumour angiogenesis: From the basic laboratory to the clinic. Clin Transl Oncol 10:468-477. doi: 10.1007/ s12094-008-0235-4
24. Zhang PH, Zou L, Tu ZG (2006) RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res 131:143-149. doi: 10.1016/j.jss.2005.09.017
25. Kang CS, Pu PY, Li YH, Zhang ZY, Qiu MZ, Huang Q, Wang GX (2005) An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor. J Neurooncol 74:267-273. doi: 10.1007/ s11060-004-8322-z
26. Christensen JG, Schreck R, Burrows J, Kuruganti P, Chan E, Le P, Chen J, Wang X, Ruslim L, Blake R, Lipson KE, Ramphal J, Do S, Cui JJ, Cherrington JM, Mendel DB (2003) A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res 63:7345-7355
27. Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J, Mazar AP, Gallick GE, Ellis LM (2005) Insulin like growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor. Ann Surg 241:748-756